Anti-TNF antibodies do not induce the apoptosis of lamina propria mononuclear cells in uninflamed intestinal tissue in patients with Crohn's disease

Folia Histochemica et Cytobiologica

Volumn 51, Issue 3, 2013, Pages 239-243

  Eder, Piotr ^a   Lykowska Szuber, Liliana ^a   Krela Kazmierczak, Iwona ^a   Stawczyk Eder, Kamila ^a   Sterzynska, Karolina ^a   Iwanik, Katarzyna ^a   Majewski, Przemyslaw ^a   Zabel, Maciej ^a   Linke, Krzysztof ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Adalimumab; Apoptosis; Crohn's disease; Infliximab; Mononuclear cells; Uninflamed mucosa

Indexed keywords

ADALIMUMAB; CASPASE 3; CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; INFLIXIMAB; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; DRUG MECHANISM; DRUG SELECTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LAMINA PROPRIA; MALE; MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIGENS, CD4; ANTIGENS, CD8; ANTIGENS, CD95; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CROHN DISEASE; FEMALE; HUMANS; INTESTINAL MUCOSA; LEUKOCYTES, MONONUCLEAR; MALE; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I;

EID: 84887379816     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.5603/FHC.2013.0034     Document Type: Article

References (15)

1. Lugering A, Lebiedz P, Koch S et al. Apoptosis as a therapeutic tool in IBD? Ann NY Acad Sci. 2006;1072:62-77.
2. Atreya R, Zimmer M, Bartsch B et al. Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF Receptor 2 and intestinal CD14+ macrophages. Gastroenterology. 2011;141:2026-2038.
3. Caprioli F, Bose F, Rossi L et al. Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy. Inflamm Bowel Dis. 2013;4:729-739.
4. Eder P, Lykowska-Szuber L, Krela-Kazmierczak I et al. The influence of infliximab and adalimumab on the expression of apoptosis-related proteins in lamina propria mononuclear cells and enterocytes in Crohn's disease - An immunohistochemical study. J Crohns Colitis. 2013;7:706-716.
5. Dignass A, Van Assche G, Lindsay JO et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management. J Crohns Colitis. 2010;4:28-62.
6. Hsu SM, Raine L, Fanger H. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981;29: 577-580.
7. Remmele W, Stegner HE. Vorschlag zur einheitlichen Definition eines immunreaktiven Score (IRS) fur den Immunohistochemichen Ostrogenrezeptor-Nachweis (ER-ICA) im Mammikarzinomgewebe. Patologie. 1987;8:138-140.
8. Ruschoff J, Dietel M, Baretton G et al. HER2 diagnostics in gastric cancer-guideline validation and development of standardized immunohistochemical testing. Virchows Arch. 2010;457:299-307.
9. Tracey D, Klareskog L, Sasso EH et al. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther. 2008;117:244-279.
10. Shen C, Assche GV, Colpaert S et al. Adalimumab induces apoptosis of human monocytes: a comparative study with infliximab and etanercept. Aliment Pharmacol Ther. 2005;21:251-258.
11. Ten Hove T, van Montfrans C, Peppelenbosch MP et al. Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease. Gut. 2002;50:206-211.
12. Ito H. IL-6 and Crohn's disease. Curr Drug Targets Inflamm Allergy. 2003;2:125-130.
13. Mudter J, Neurath MF. Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications. Gut. 2007;56:293-303.
14. Ricciardelli I, Lindley KJ, Londei M et al. Anti tumour necrosis- alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease. Immunology. 2008;2:178-183.
15. Vos AC, Wildenberg ME, Duijvestein M et al. Anti-tumor necrosis factor-a antibodies induce regulatory macrophages in an Fc region-dependent manner. Gastroenterology. 2011;1:221-230.